Morgan Stanley (MS) Reports Q3 Earnings: What Key Metrics Have to Say
Werte in diesem Artikel
Morgan Stanley (MS) reported $18.22 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 18.5%. EPS of $2.80 for the same period compares to $1.88 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $16.45 billion, representing a surprise of +10.8%. The company delivered an EPS surprise of +34.62%, with the consensus EPS estimate being $2.08.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Morgan Stanley performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Book value per common share: $62.98 compared to the $62.22 average estimate based on four analysts.Return on average common equity: 18% versus 12.9% estimated by four analysts on average.Wealth Management - Total client assets: $7,054.00 billion compared to the $6,479.11 billion average estimate based on two analysts.Total assets under management: $1,807.00 billion compared to the $1,731.11 billion average estimate based on two analysts.Revenues- Investment banking: $2.27 billion versus the three-analyst average estimate of $1.79 billion. The reported number represents a year-over-year change of +42.5%.Revenues- Commissions and fees: $1.47 billion compared to the $1.39 billion average estimate based on three analysts. The reported number represents a change of +13.8% year over year.Revenues- Institutional securities- Sales and Trading- Fixed income: $2.17 billion compared to the $2.06 billion average estimate based on three analysts. The reported number represents a change of +8.3% year over year.Revenues- Institutional securities- Sales and trading- Equity: $4.12 billion compared to the $3.22 billion average estimate based on three analysts. The reported number represents a change of +35.2% year over year.Revenues- Institutional securities- Other: $130 million versus $230.43 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -57.2% change.Revenues- Institutional securities- Investment banking: $2.11 billion compared to the $1.52 billion average estimate based on three analysts. The reported number represents a change of +44.1% year over year.Net revenues- Investment Management: $1.65 billion versus $1.52 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +13.5% change.Net revenues- Institutional Securities: $8.52 billion versus $7.03 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +25.1% change.View all Key Company Metrics for Morgan Stanley here>>>Shares of Morgan Stanley have returned -0.3% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Morgan Stanley (MS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Morgan Stanley und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf CGI Group
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CGI Group
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Morgan Stanley
Analysen zu Morgan Stanley
Datum | Rating | Analyst | |
---|---|---|---|
16.07.2024 | Morgan Stanley Neutral | UBS AG | |
19.04.2023 | Morgan Stanley Buy | Jefferies & Company Inc. | |
14.04.2022 | Morgan Stanley Buy | Goldman Sachs Group Inc. | |
28.09.2021 | Morgan Stanley Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
20.04.2021 | Morgan Stanley kaufen | Credit Suisse Group |
Datum | Rating | Analyst | |
---|---|---|---|
19.04.2023 | Morgan Stanley Buy | Jefferies & Company Inc. | |
14.04.2022 | Morgan Stanley Buy | Goldman Sachs Group Inc. | |
20.04.2021 | Morgan Stanley kaufen | Credit Suisse Group | |
15.10.2020 | Morgan Stanley Outperform | RBC Capital Markets | |
05.10.2020 | Morgan Stanley Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
16.07.2024 | Morgan Stanley Neutral | UBS AG | |
28.09.2021 | Morgan Stanley Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
02.04.2020 | Morgan Stanley neutral | Deutsche Bank AG | |
21.01.2020 | Morgan Stanley Neutral | Citigroup Corp. | |
04.04.2019 | Morgan Stanley Hold | HSBC |
Datum | Rating | Analyst | |
---|---|---|---|
20.01.2016 | Morgan Stanley Sell | Société Générale Group S.A. (SG) | |
25.07.2011 | Morgan Stanley underperform | RBC Capital Markets | |
02.10.2009 | Morgan Stanley underperform | Calyon Securities Inc. | |
31.08.2005 | Morgan Stanley underweight | Prudential Financial | |
28.07.2005 | Morgan Stanley underweight | Prudential Financial |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Morgan Stanley nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen